http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001002587-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3dd802bf7a53f5320961a7f060aa02a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 1999-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36fae1358b1d1129b994a61f3854baca |
| publicationDate | 2001-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2001002587-A |
| titleOfInvention | HGF production enhancer |
| abstract | (57) [Problem] To provide an HGF production improving agent. SOLUTION: The HGF production enhancer according to the present invention comprises an angiotensin-converting enzyme (Angiotensin-Converting Enzyme). At least one selected from the group consisting of an inhibitor and an angiotensin II receptor antagonist is contained as an active ingredient. ADVANTAGE OF THE INVENTION According to this invention, the production | generation of HGF in a living body can be improved, and the effect of being able to promote the healing of the damage | damage of the tissues, organs, etc. of a living body is exhibited. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02087503-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02087503-A2 |
| priorityDate | 1999-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.